Cutera, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2020
February 16, 2021
Share
Cutera, Inc. reported Unaudited Consolidated earnings results for the fourth quarter and full year ended December 31, 2020. For the quarter, the company reported total net revenue of $49,943,000 compared to $51,795,000 a year ago. Income from operations was $1,443,000 compared to loss from Operation of $1,929,000 a year ago. Net income was $2,188,000 compared to net loss of $2,088,000 a year ago. Basic and diluted net income per share was $0.12 compared to basic and diluted net loss per share of $0.15 a year ago.
For the full year, the company reported total net revenue of $147,683,000 compared to $181,712,000 a year ago. Loss from operations was $22,828, 000 compared to loss from Operation of $12,064,000 a year ago. Net loss was $23,877,000 compared to net loss of $12,348,000 a year ago. Basic and diluted net loss per share was $1.43 compared to basic and diluted net loss per share of $0.88 a year ago.
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Companyâs Cutera Core segment consists of the Companyâs systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Companyâs AviClear segment consists of the AviClear business. The Companyâs acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.